Anfield Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,386
Closed -$16K 95
2022
Q3
$16K Buy
1,386
+36
+3% +$494 0.01% 86
2022
Q2
$20K Buy
1,350
+144
+12% +$2.36K 0.01% 88
2022
Q1
$23K Buy
1,206
+660
+121% +$11.8K 0.01% 87
2021
Q4
$9K Buy
546
+505
+1,232% +$8.6K ﹤0.01% 94
2021
Q3
$1K Buy
+41
New +$613 ﹤0.01% 115

Other funds holding INVA

Anfield Capital Management's INVA Position: Q4 2022 in Review

Anfield Capital Management sold out of Innoviva (INVA) in Q4 2022, closing a stake of 1,386 shares — an estimated $16K sold.

Anfield Capital Management first reported a position in INVA in Q3 2021 and held it in 5 quarters. The position peaked at $23K in Q1 2022. 209 funds tracked by Wall St. Rank hold INVA as of Q4 2022.

  • Anfield Capital Management reported no remaining Innoviva position as of Q4 2022 after selling out during the quarter.
  • Anfield Capital Management sold 1,386 Innoviva shares in Q4 2022, an estimated $16K.
  • Anfield Capital Management first reported a position in Innoviva in Q3 2021 and held it in 5 quarters.
  • Anfield Capital Management's Innoviva position peaked at $23K in Q1 2022.
  • 209 funds tracked by Wall St. Rank held Innoviva as of Q4 2022.

Based on Anfield Capital Management's 13F filing for Q4 2022, filed 1 Feb 2023.